Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.

Intel Capital and Wipro Ventures have exited machine learning-based data management platform Imanis Data, which has been bought by Cohesity.

Salesforce Ventures' Canada Trailblazer Fund took part in a $23m round for the commerce services provider that was led by Delta-v Capital.

University of Wyoming has spun out Wyomics to commercialise an ionic liquid product for extracting valuable materials including rare earth elements from coal and fly ash resources.

Regenerative medicine spinout LifeSprout is advancing JHU research into a nanofibre-fortified gel that can be injected to repair soft tissue.

Edgewell Personal Care has agreed to acquire razor subscription service Harry’s in a cash and stock transaction that will allow Grace Beauty Capital to exit.

OUP and Sofinnova Partners invested in 28-7 Therapeutics to take its series A round to $82.8m, enabling the Harvard spinout to pursue accelerated development of its cancer drug pipeline.

SoftBank Vision Fund is selling $245m of shares while PayPal is investing $500m in the ride hailing service, in the world's largest IPO since 2014.

Milestone, a cardiovascular nasal spray developer that raised more than $167m in VC funding from investors including Novo, secured $82.5m in when it went public.

Network technology provider Altiostar has closed a $114m series C round after Rakuten added to Qualcomm Ventures and Tech Mahindra's contributions.